This opportunity is now closed.

Funded PhD Opportunity

Next generation analyses in B cell chronic lymphoproliferative disorders: generation of multi-omics datasets in multiple myeloma to enhance understanding of the biology of the tumour cell.

Subject: Biomedical Sciences


Summary

Multiple Myeloma (MM), is an incurable haematological malignancy of end stage B lineage cells, or plasma cells. It has an incidence of approximately 65 new cases per million of the population per annum, with a male:female ratio of 1.3:1 and shows differences in incidence in different ethnic groups. Overall survivals have improved recently from a median of 3–4 years to 5–7 years, although upwards of 25% of patients survive for less than 24 months. Major obstacles to improved outcomes are the disease’s heterogeneity, drug resistance and the immunosuppressive nature of the tumour in its bone marrow microenvironment. Monoclonal Gammopathy of Undetermined Significance (MGUS), from which most cases of MM are thought to evolve, has an incidence of 3-4% in the over 50 age group, with 1% of cases progressing to MM per annum. Smouldering Multiple Myeloma (SMM) constitutes approximately 14% of all cases of myeloma and carries a 10% risk per annum of progression to MM. Factors contributing to progression of these conditions are unclear.

There is an urgent need to improve understanding of their biology and identify biomarkers to enable prediction of disease progression, and responsiveness to specific treatments. This is a longitudinal study, with serial sampling of patients at different time points. Named collaborators include NHS clinicians caring for the patients. Significant preliminary findings include identification of tumour plasma cells in peripheral blood (PB) in approximately half the patients tested to date, including some with MGUS and some MM patients considered to be in complete remission (CR) using conventional criteria. Using multicolour flow cytometry, these cells are sorted and stored for future molecular analyses. Cellular, plasma and serum markers will be analysed on all patients, at each sampling time-point, to improve understanding of the clinical immunosupression that occurs and biological processes involved in disease progression, efficacy of, or resistance to, specific therapies, and identification of biomarkers which could be applied in clinical practice to enhance outcomes.

Most previous studies have used cell lines, or single patient samples only allowing a snapshot at one time-point. Serial sampling will facilitate analyses of tumour cells from presentation/diagnosis through to the almost inevitable relapse and development of drug resistance in terminal stages. This will contribute to improved understanding of proliferation, survival and drug resistance factors involved in disease progression in individual patients, the pathways involved, and may identify novel therapeutic targets for future drug development.

Specific investigations planned involve generation of large multi-omics datasets.Techniques will include next generation cellular, proteomic and molecular analyses available at NICSM, or outsourced to specialised laboratories in Europe and N America. Project will be mainly wet-lab based, with some bioinformatics components. Thus, we are seeking a student having a strong interest in cellular, proteomic and molecular investigations in oncology, in particular haemato-oncology. Knowledge of the innate and adaptive immune systems, and statistics/bioinformatics will be an added advantage.

For any informal enquiry and/or to discuss more about the project, please contact the supervisors: Dr Priyank Shukla (p.shukla@ulster.ac.uk), Professor Denis Alexander (d.alexander@ulster.ac.uk) and Professor Tony Bjourson (aj.bjourson@ulster.ac.uk).


Essential criteria

  • To hold, or expect to achieve by 15 August, an Upper Second Class Honours (2:1) Degree or equivalent from a UK institution (or overseas award deemed to be equivalent via UK NARIC) in a related or cognate field.
  • Sound understanding of subject area as evidenced by a comprehensive research proposal
  • A comprehensive and articulate personal statement

Desirable Criteria

If the University receives a large number of applicants for the project, the following desirable criteria may be applied to shortlist applicants for interview.

  • First Class Honours (1st) Degree
  • Completion of Masters at a level equivalent to commendation or distinction at Ulster
  • Research project completion within taught Masters degree or MRES
  • Experience using research methods or other approaches relevant to the subject domain
  • Work experience relevant to the proposed project
  • Publications - peer-reviewed
  • Experience of presentation of research findings

Funding

    The University offers the following awards to support PhD study and applications are invited from UK, EU and overseas for the following levels of support:

    Vice Chancellors Research Studentship (VCRS)

    Full award (full-time PhD fees + DfE level of maintenance grant + RTSG for 3 years).

    This scholarship will cover full-time PhD tuition fees and provide the recipient with £15,000 maintenance grant per annum for three years (subject to satisfactory academic performance). This scholarship also comes with £900 per annum for three years as a research training support grant (RTSG) allocation to help support the PhD researcher.

    Vice-Chancellor’s Research Bursary (VCRB)

    Part award (full-time PhD fees + 50% DfE level of maintenance grant + RTSG for 3 years).

    This scholarship will cover full-time PhD tuition fees and provide the recipient with £7,500 maintenance grant per annum for three years (subject to satisfactory academic performance). This scholarship also comes with £900 per annum for three years as a research training support grant (RTSG) allocation to help support the PhD researcher.

    Vice-Chancellor’s Research Fees Bursary (VCRFB)

    Fees only award (PhD fees + RTSG for 3 years).

    This scholarship will cover full-time PhD tuition fees for three years (subject to satisfactory academic performance). This scholarship also comes with £900 per annum for three years as a research training support grant (RTSG) allocation to help support the PhD researcher.

    Department for the Economy (DFE)

    The scholarship will cover tuition fees at the Home rate and a maintenance allowance of £ 15,009 per annum for three years. EU applicants will only be eligible for the fee’s component of the studentship (no maintenance award is provided). For Non-EU nationals the candidate must be "settled" in the UK. This scholarship also comes with £900 per annum for three years as a research training support grant (RTSG) allocation to help support the PhD researcher.

    Due consideration should be given to financing your studies; for further information on cost of living etc. please refer to: www.ulster.ac.uk/doctoralcollege/postgraduate-research/fees-and-funding/financing-your-studies


Other information


The Doctoral College at Ulster University


Reviews

Profile picture of Kieran O'Donnell

My experience has been great and the people that I have worked with have been amazing

Kieran O'Donnell - 3D printing of biological cells for tissue engineering applications

Watch Video  

Profile picture of Michelle Clements Clements

Completing the MRes provided me with a lot of different skills, particularly in research methods and lab skills.

Michelle Clements Clements - MRes - Life and Health Sciences

Watch Video  

Profile picture of William Crowe

Throughout my PhD I’ve been provided with continuous support and guidance by my supervisors and the staff at the University.I’ve also received many opportunities to further enhance my professional development in the form of teaching experience and presenting my work at conferences which will aid in my pursuit of a career in academia or industry.

William Crowe


Key dates

Submission deadline
Monday 19 February 2018

Interview Date
6, 7 and 8 March 2018


Applying

Apply Online  


Contact supervisor

Dr Priyank Shukla


Other supervisors

Related Funded Opportunities

Role of B-vitamins in Epigenetic Modulation of Hypertension

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Engineering plasmid nanoparticles as a platform for delivery of therapeutics

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Diabetes

Subject: Biomedical Sciences

 View details

Graphene family materials as novel chronic wound therapeutics

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences|Computer Science and Informatics

 View details

Investigation of microRNA regulation and function in prostate cancer

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Role of novel cardiac biomarkers in cellular senescence

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Oxygen-generating biomaterials for use in wound dressing strategies

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences|Computer Science and Informatics

 View details

Development and evaluation of a web-based interactive teaching tool for Optometrists

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences|Computer Science and Informatics

 View details

The production of rhamnolipid biosurfactant by Pseudomonas aeruginosa growing in biofilms.

Closing date:
Tuesday 1 September 2020
Subject: Biomedical Sciences

 View details

The regulation of rhamnolipid biosynthesis in Burkholderia thailandensis.

Closing date:
Tuesday 1 September 2020
Subject: Biomedical Sciences

 View details

Naturally-occurring microbial biosynthetic pathways for propane

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Genomic Medicine

Subject: Biomedical Sciences

 View details

Novel fatty acid receptors in islet cells as therapeutic targets for diabetes

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Interactome visualisation of ALS using virtual reality

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Stratified Medicine

Subject: Biomedical Sciences

 View details

Novel amphibian skin peptide-analogues for the treatment of type-2 diabetes

Closing date:
Friday 18 September 2020
Subject: Biomedical Sciences

 View details

Blue whiting protein hydrolysates for management of sarcopenia

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Targeted exendin/apelin hybrid peptides for diabetes and obesity therapy.

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Optometry and Vision Science

Subject: Biomedical Sciences

 View details

MRes in Biomedical Sciences

Subject: Biomedical Sciences

 View details

Regulation of glucose metabolism by incretin signalling

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Mental Health Diagnosis using Cognitive Analytics

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences|Psychology, Psychiatry and Neuroscience

 View details

Identifying biomarkers that may affect diabetes comorbidity

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

The Growing Problem of Myopia: are spectacles part of the problem?

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Improving the screening and diagnosis of familial hypercholesterolemia

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences|Computer Science and Informatics

 View details

Computational approaches to investigate multimorbidity in depression

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

The role of dietary fatty acids and the gut microbiota on autoimmunity

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

A novel therapeutic targeting the inflammasome as a treatment for glaucoma.

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Nutrition and the gut microbiome: impact on brain health in older adults

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Investigation of oral and blood microbiome shifts in patients with depression.

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Vitamin D across the lifecycle to inform nutritional policies

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Epigenomic Profiling of Young Adults with Mental Health Disorders in Northern Ireland

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Investigation of the modifying effects of selenium in the relationship between methylmercury and child development

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences|Biomedical Sciences

 View details

Towards seeing clearly: does the shape of the eye’s optics affect our focus?

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Changing dietary patterns in the Seychelles and implications for public health

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details